John S. Patton Net Worth & Insider Trades

John S. Patton - Director, Halozyme Therapeutics Inc

As of May 16, 2013

What is John S. Patton's Net Worth?

The current estimated net worth of Halozyme Therapeutics Inc's Director, John S. Patton, is estimated to be about $15.05M . John S. Patton owns about 15,000 units of Halozyme Therapeutics Inc common stock. In the last 6 years at Halozyme Therapeutics Inc, John S. Patton has sold an estimated value of $2.04M worth.

What is John S. Patton's Past Insider Trading?

John S. Patton's largest sale order was 20,000 units , worth over $211.13K on May 23, 2007. In total, John S. Patton has made about 18 transactions over 6 years of their time at Halozyme Therapeutics Inc. John S. Patton usually trades in May, with the busiest year in 2007. The most recent transaction was a sale order of 15,000 units , worth over $135.63K on October 18, 2007.

John Stuart Patton

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John S. Patton's' Mailing Address?

  • Mailing address is 150 Industrial Road C/o Nektar Therapeutics San Carlos CA 94070 CA

Halozyme Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

What are Halozyme Therapeutics Inc's Past Insider Trades?

Halozyme Therapeutics Inc's most recent insider trade came on November 17, 2022 by Helen Torley who sold 30,000 units worth $1.6M . In the last 15 years, insiders at Halozyme Therapeutics Inc have sold an estimated value of $133.92M and bought an estimated value of $81.73M worth of shares. Insider trading is most common in February and May, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk .

HALOZYME THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1